Literature DB >> 23127245

Decreased activities of daily living is a strong risk factor for liver injury by anti-tuberculosis drugs.

Nobuyuki Horita1, Naoki Miyazawa, Takashi Yoshiyama, Toshinori Tsukahara, Ryohei Takahashi, Jun Tsukiji, Hideaki Kato, Takeshi Kaneko, Yoshiaki Ishigatsubo.   

Abstract

BACKGROUND AND
OBJECTIVE: We evaluated the association between activities of daily living and drug-induced liver injury by anti-tuberculosis drugs.
METHODS: This retrospective cohort study included adult inpatients with newly diagnosed smear-positive lung tuberculosis treated with standard regimen in two hospitals. (n = 346; 63.6 ± 20.3 years old; 106 (30.6%) females). Activities of daily living was divided into 'independent' (Barthel Index (BI) 80-100, 60.4%) and 'decreased' (BI 0-75, 39.6%) categories. Liver injury was defined as the withdrawal or change of treatment regimen on the basis of the following criteria: serum transaminase concentrations were more than three times the upper limit of normal range with jaundice and/or hepatitis symptoms, or more than five times the upper limit of the normal range.
RESULTS: Compared with 'independent' patients, patients with 'decreased' activities of daily living had odds ratios for liver injury of 4.2 (P < 0.001) in univariate analysis and 5.7 (P = 0.002) in logistic regression analysis after adjusting for other risk factors.
CONCLUSIONS: Decreased activity of daily living is a strong risk factor for liver injury among adult inpatients with newly diagnosed smear-positive lung tuberculosis treated using a standard regimen.
© 2013 The Authors. Respirology © 2013 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23127245     DOI: 10.1111/resp.12008

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  6 in total

Review 1.  Year in review 2013: Lung cancer, respiratory infections, tuberculosis, cystic fibrosis, pleural diseases, bronchoscopic intervention and imaging.

Authors:  Chi Chiu Leung; José M Porcel; Kazuhisa Takahashi; Marcos I Restrepo; Pyng Lee; Claire Wainwright
Journal:  Respirology       Date:  2014-02-21       Impact factor: 6.424

2.  HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients.

Authors:  Ken Tashiro; Nobuyuki Horita; Kenjiro Nagai; Misako Ikeda; Masaharu Shinkai; Masaki Yamamoto; Takashi Sato; Yu Hara; Hideyuki Nagakura; Yuji Shibata; Hiroki Watanabe; Kentaro Nakashima; Ryota Ushio; Akimichi Nagashima; Atsuya Narita; Nobuaki Kobayashi; Makoto Kudo; Takeshi Kaneko
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

3.  The Platelet Count Can Predict In-hospital Death in HIV-negative Smear-positive Pulmonary Tuberculosis Inpatients.

Authors:  Hideto Goto; Nobuyuki Horita; Ken Tashiro; Kenjiro Nagai; Masaki Yamamoto; Takashi Sato; Yu Hara; Hideyuki Nagakura; Yuji Shibata; Hiroki Watanabe; Kentaro Nakashima; Ryota Ushio; Akimichi Nagashima; Misako Ikeda; Atsuya Narita; Katsuhito Sasaki; Nobuaki Kobayashi; Makoto Kudo; Takeshi Kaneko
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

4.  Is rehabilitation effective in preventing decreased functional status after community-acquired pneumonia in elderly patients? Results from a multicentre, retrospective observational study.

Authors:  Hao Chen; Yu Hara; Nobuyuki Horita; Yusuke Saigusa; Yoshihiro Hirai; Takeshi Kaneko
Journal:  BMJ Open       Date:  2022-09-15       Impact factor: 3.006

5.  Age, Dehydration, Respiratory Failure, Orientation Disturbance, and Blood Pressure Score Predicts In-hospital Mortality in HIV-negative Non-multidrug-resistant Smear-positive Pulmonary Tuberculosis in Japan.

Authors:  Kenjiro Nagai; Nobuyuki Horita; Takashi Sato; Masaki Yamamoto; Hideyuki Nagakura; Takeshi Kaneko
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

6.  Safety and Efficacy of Nontuberculous Mycobacteria Treatment among Elderly Patients.

Authors:  Yoshitaka Uchida; Jiro Terada; Tetsuya Homma; Hatsuko Mikuni; Kuniaki Hirai; Haruhisa Saito; Ryoichi Honda; Hironori Sagara
Journal:  Medicina (Kaunas)       Date:  2020-10-02       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.